Sign Up to Receive Your Personalised Learning Resources
JOURNALS
SARS-CoV-2 mRNA vaccination associated with increased survival in patients with lung cancer and melanoma treated with immune checkpoint inhibitors
Start Learning
Multidisciplinary insights: Navigating the challenges of systemic mastocytosis diagnosis and management
Knowledge for nurses: ADC updates in breast cancer
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life
Olutasidenib for Adults with Relapsed or Refractory Acute Myeloid Leukaemia with Isocitrate Dehydrogenase 1 Mutation
Global Liver Institute launches #OctoberIs4Livers campaign to combat rising liver cancer rates
Addition of nivolumab to rucaparib did not improve clinical outcomes in newly diagnosed, advanced, high-grade ovarian cancer
A Comprehensive Review of the Growing Landscape of Endocrine and Biologic Treatments for Hormone Receptor-positive Breast Cancer
Fruquintinib in Patients with Previously Treated Metastatic Colorectal Cancer
Futibatinib for the Treatment of Previously Treated, Unresectable, Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma with Fibroblast Growth Factor Receptor 2 (FGFR2) Gene Fusions or Other Rearrangements
Expanding HER2 horizons: Implications for NSCLC and beyond
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
Advancing upper gastrointestinal cancer care: Insights from Dr Ken Kato on Japan’s clinical research and future innovations
View
Project Cure CRC Awards Nearly $5 Million to Accelerate Advancements in Care
View
Expanding HER2 horizons: Implications for NSCLC and beyond
View
Project Cure CRC pushes for cutting-edge innovations in colorectal cancer care
View
Decoding HER2 in NSCLC: Advances in biomarker testing and targeted therapies
View
Highlights from ESMO GI 2024
View
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
View
Trastuzumab Deruxtecan for the Treatment of HER2-low Advanced or Metastatic Breast Cancer
View
Niraparib as first-line maintenance treatment in ovarian cancer
View
Fruquintinib in Patients with Previously Treated Metastatic Colorectal Cancer
View
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
